News

Analyzing Trends: Options Activity of Upstart Holdings Inc.

Analyzing Trends: Options Activity of Upstart Holdings Inc.

Understanding Upstart Holdings Inc. Options Activity

In the world of stock trading, monitoring options activity gives investors a unique perspective on market sentiment. Recently, there's been a surge in interest around Upstart Holdings Inc. as whales have exhibited a notably bullish outlook.

By delving into the options history for Upstart Holdings (NASDAQ: UPST), we discovered 32 significant trades suggesting a strong belief in the stock's potential. Interestingly, of these trades, 46% were made with bullish expectations, while 37% reflected bearish sentiment.

Highlights of Trading Activity

Out of the total transactions tracked, there have been 17 put options traded amounting to $2,197,084 in total value, alongside 15 call options with a total worth of $723,858. These figures present a balanced view of optimism coupled with caution among traders.

Price Band Focus

Analyzing the trends over the last three months reveals that market movers primarily concentrate their interests between the $45.00 and $120.00 price range for Upstart Holdings. This critical range provides insight into where traders believe the stock may be heading based on current market dynamics.

Volume & Open Interest Analysis

Understanding trading volume and open interest is crucial for investors seeking to gauge the liquidity and interest around Upstart's options. These metrics offer a clearer picture of where the stock's potential action could lie.

Over the past 30 days, the evolution of both call and put volumes shows a notable increase in whale activity within the identified strike price range. This spike indicates heightened investor engagement, potentially driven by speculation or forthcoming market announcements.

Recent Noteworthy Options

This recent surge in options trading reflects a mix of high-stakes entries from various investors. The trades noted include several large transactions, where strong interest is evident in both the bullish and neutral sentiment surrounding the stock:

  • Trade Type: SWEEP | Sentiment: BULLISH | Total Trade Price: $355,400 | Expiry: 03/21/25 | Strike Price: $75.00
  • Trade Type: SWEEP | Sentiment: NEUTRAL | Total Trade Price: $190,100 | Expiry: 03/21/25 | Strike Price: $68.00
  • Trade Type: TRADE | Sentiment: BULLISH | Total Trade Price: $249,700 | Expiry: 01/16/26 | Strike Price: $65.00

About Upstart Holdings Inc.

Upstart Holdings Inc offers innovative credit services, leveraging its proprietary cloud-based artificial intelligence lending platform. This technology effectively aggregates consumer demand for loans and connects it to its network of AI-enabled banking partners, facilitating personal loans, automotive financing, home equity lines, and more.

Current Market Position

As it stands, the trading volume for Upstart is recorded at 3,971,479, with the stock price slightly declining to $70.66. The overall market sentiment is indeed cautious, as reflected by the RSI indicators indicating possible overbought conditions.

Investors are also anticipating an earnings announcement that is expected soon, which could further influence trading dynamics.

Expert Analyst Insights

Recently, five professional analysts have provided their assessments of Upstart's stock performance, assigning an average target price of $82.4. Their varied opinions highlight a mixture of cautious optimism and potential adjustments based on market conditions.

Furthermore, one analyst from B. Riley Securities has raised their rating to Buy, with a new target at $105. In contrast, Goldman Sachs maintains a Sell rating with a lower target price of $15. JP Morgan has also shown a degree of optimism by lifting its rating to Neutral, with a target of $79.

As investors navigate the complexities of options trading, it is crucial to stay informed and adapt strategies based on real-time market movements. Engaging with ongoing analysis can significantly enhance decision-making for stocks like Upstart Holdings.

Frequently Asked Questions

What is the recent options activity for Upstart Holdings?

Recently, there were 32 trades detected for Upstart, with 46% being bullish and 37% bearish.

What is the primary price range being monitored for Upstart?

Market movers are focusing on a price band between $45.00 and $120.00 for Upstart Holdings.

What does the volume and open interest data signify?

This data shows the liquidity and interest levels in Upstart's options, suggesting investor engagement within specific price ranges.

What are analysts saying about Upstart Holdings?

The average price target set by analysts is $82.4, with varying opinions on the stock's future performance.

What should investors keep in mind regarding options trading?

Options trading involves higher risks; thus, continued education and market monitoring are essential for successful trading strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 99

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 211

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 138

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 136

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

CNX Resources Reveals Third Quarter Results and Upcoming Call

Updated Category News Views 36

CNX Resources Corporation Financial Update CNX Resources Corporation (NYSE: CNX) is gearing up to announce its financial outcomes for the third quarter of 2024. This announcement is scheduled for 6:45 a.m. Eastern Time on a Thursday morning toward the end of October. During this time, CNX will also share essential materials, including remarks prepared for the quarter,...

Continue Reading
MBZUAI Enhances Research Collaboration with École Polytechnique

Updated Category News Views 183

Strengthening Research Cooperation Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has officially expanded its strategic partnership with École Polytechnique, aiming for a more profound collaboration in artificial intelligence (AI) research. This new Collaborative Research Agreement is a significant step towards enhancing research capabilities in both...

Continue Reading
Projected Growth of Marine Collagen: Key Insights and Trends

Updated Category News Views 152

The Growing Marine Collagen Market The marine collagen market is set to experience significant growth in the coming years. As consumer awareness around health and beauty continues to rise, we see a shift in preference towards marine collagen, thanks to its impressive bioavailability and sustainable sourcing methods. Recent analyses reveal that this sector is predicted to...

Continue Reading
BioLife Solutions Prepares for Q1 2025 Financial Disclosure

Updated Category News Views 144

Exciting Financial Insights Awaiting from BioLife Solutions BioLife Solutions, Inc. (NASDAQ: BLFS) has announced that it will disclose its first quarter 2025 financial results, marking an important update for investors and stakeholders alike. This revelation is set to occur after the market closes, creating anticipation among those closely monitoring the company’s...

Continue Reading
FuboTV Achieves Record Subscriber Growth in North America

Updated Category News Views 174

FuboTV Reports Unprecedented Subscriber Growth FuboTV (NYSE: FUBO) has recently made headlines as it recorded the highest-ever growth in its North American subscriber base. This achievement highlights the company’s potential in the competitive streaming industry. The stock saw a notable increase on the day the company announced its earnings for the third quarter....

Continue Reading